Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will present ...

Organ transplants not only save lives, they transform them. For our vital organs like hearts and lungs the impact of a ...

Q2 2025 Earnings Call Transcript July 31, 2025 Operator: Good afternoon, and welcome to TransMedics Second Quarter 2025 ...

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today ...

While chemotherapy remains a cornerstone of lung cancer treatment, it often weakens the immune system it relies on for ...

TransMedics posted strong Q2 results with solid growth and improving margins, while heart and lung programs offer key upside.

Ben Askren, the 41-year-old former UFC fighter and Olympic wrestler, has returned home after a 59-day hospital stay. He ...

TransMedics Group (NASDAQ:TMDX) beat GAAP revenue and earnings estimates for the second quarter of 2025, with GAAP revenue up 38% year over year. GAAP EPS more than doubled versus analyst forecasts, ...

Event: Canaccord Genuity 45th Annual Growth Conference Date: Tuesday, August 12, 2025 Time: 11:30 a.m. ET A live and archived webcast of the fireside chat will be available on the “Investors” section ...

Medical experts conduct several tests to assess the health of the donor’s organs and other critical health details ...